Collplant Holdings Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
CLGN
IL0004960188
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- ILa | -.--% | -14.91% | -.--% |
Sales 2024 * | 10.53M 2.79M 1.05B | Sales 2025 * | 53.98M 14.28M 5.4B | Capitalization | 234M 61.98M 23.43B |
---|---|---|---|---|---|
Net income 2024 * | -60M -15.87M -6B | Net income 2025 * | -24M -6.35M -2.4B | EV / Sales 2024 * | 22.2 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 4.34 x |
P/E ratio 2024 * |
-3.81
x | P/E ratio 2025 * |
-9.49
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.27% |
Managers | Title | Age | Since |
---|---|---|---|
Yehiel Tal
CEO | Chief Executive Officer | 71 | 09-12-31 |
Oded Shoseyov
FOU | Founder | 67 | 04-05-31 |
Eran Rotem
DFI | Director of Finance/CFO | 56 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Avri Havron
BRD | Director/Board Member | 75 | 16-04-30 |
Hugh Evans
BRD | Director/Board Member | 57 | 21-03-28 |
Elan Penn
BRD | Director/Board Member | 72 | 17-12-31 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.68% | 961M | |
-18.52% | 131M | |
+7.32% | 63.05M | |
+1.20% | 50.36M |
- Stock Market
- Equities
- CLGN Stock
- CLGN Stock